South Korea-based International Vaccine Institute (IVI) and Bio Farma, a biotechnology company based in West Java, Indon...
The US Food and Drug Administration (FDA) has approved Ixchiq, the first chikungunya vaccine, developed by Valneva ...
On 9 November, Hilleman Laboratories opened its ACES current Good Manufacturing Practices (cGMP) facility in Singapore w...
Four vaccine hubs have received a share of £33 million of UK aid funding via the Department of Health and Soc...
The Netherlands Ministry of Health, Sports and Welfare has announced an additional EUR 14 million contribution to Norway...
South Korea-based SK bioscience recently announced that Dr Jean Kaseya, Director General, African Centers...
South Korea-based International Vaccine Institute (IVI) has partnered with KEMRI-Wellcome Trust Research Programme (KWTR...
Norway-based Coalition for Epidemic Preparedness Innovations (CEPI) and American firm Moderna, Inc. have entered into ...
Australia-based Griffith University’s Institute for Glycomics has received a $5 million philanthropic donation fro...
As the world is progressively rebounding from pandemic impact, Moderna is constantly developing next-generation combinat...
The Peter Doherty Institute for Infection and Immunity, a joint venture between the University of Melbourne and the Roya...
The Ministry of Health and Welfare in South Korea has announced that the Ministry and the Asian Development Bank (ADB) a...
A novel glycoengineering platform, created by the researchers at Yong Loo Lin School of Medicine, National University of...
British pharmaceutical firm GlaxoSmithKline (GSK) has reached an exclusive agreement with Chongqing Zhifei Biologic...
At the recently held 2023 Grand Challenges Annual Meeting, Bill Gates, Co-chair of the Bill & Melinda Gates Foundati...
The Global Health Innovative Technology Fund (GHIT Fund), headquartered in Japan, and the Institut Pasteur de Dakar (IPD...
Dr Deckster Tonny SAVADYE, CEO of Zimbabwe National Biotechnology Authority (NBA), and Dr Yang Yili, Internati...
UK-based Emergex Vaccines Holding has signed a Memorandum of Understanding with the Saudi Arabia-based startup Vaccine I...
